表紙:ジェネリック医薬品の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)
市場調査レポート
商品コード
1028825

ジェネリック医薬品の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)

Generic Pharmaceuticals Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
ジェネリック医薬品の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のジェネリック医薬品の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し、セグメント別 (治療内容別・流通チャネル別) および地域別・主要国の詳細動向、主要企業のプロファイル、近年の主な傾向、今後の市場機会などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 ジェネリック医薬品市場の特徴

第3章 ジェネリック医薬品市場の傾向と戦略

第4章 ジェネリック医薬品市場に対する新型コロナウイルス感染症 (COVID-19) の影響

第5章 ジェネリック医薬品市場:市場規模・成長率

  • 市場規模 (単位:10億米ドル、2015年~2020年)
    • 市場促進要因
    • 市場抑制要因
  • 市場規模 (単位:10億米ドル、2020年~2025年、2030年)
    • 市場促進要因
    • 市場抑制要因

第6章 ジェネリック医薬品市場:分野別の分析

  • 治療内容別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 中枢神経系 (CNS)
  • 心血管
  • 皮膚
  • 泌尿生殖器/ホルモン
  • 呼吸器
  • リウマチ
  • 糖尿病
  • 腫瘍
  • 流通チャネル別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 種類別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • バイオシミラー
  • シンプルジェネリック
  • スーパージェネリック
  • 薬剤送達別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 経口投与
  • 注入投与
  • 皮膚/局所投与
  • 吸入投与

第7章 ジェネリック医薬品市場:地域別・国別分析

  • 地域別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 国別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)

第8章 アジア太平洋のジェネリック医薬品市場

  • 市場概要
  • 地域情報
  • 治療内容別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)
  • 流通チャネル別の市場規模 (単位:10億米ドル、2015年~2020年/2020年~2025年/2030年)

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧のジェネリック医薬品市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 東欧のジェネリック医薬品市場

第20章 ロシア市場

第21章 北米のジェネリック医薬品市場

第22章 米国市場

第23章 南米のジェネリック医薬品市場

第24章 ブラジル市場

第25章 中東のジェネリック医薬品市場

第26章 アフリカのジェネリック医薬品市場

第27章 ジェネリック医薬品市場:競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Teva Pharmaceuticals
    • Mylan NV
    • Sandoz International GmbH
    • Hospira(Pfizer Inc.)
    • Sun Pharmaceutical

第28章 ジェネリック医薬品のパイプライン製品の分析

第29章 ジェネリック医薬品市場における主要な企業合併・買収 (M&A)

第30章 ジェネリック医薬品市場:将来展望と潜在力の分析

第31章 付録

目次
Product Code: h849

Generic Pharmaceuticals Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market.

The report focuses on the generic pharmaceuticals market which is experiencing strong growth. The report gives a guide to the generic pharmaceuticals market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the generic pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Generic Pharmaceuticals Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Therapy: CNS; Cardiovascular; Dermatology; Genitourinary/Harmonal; Respiratory; Rheumatology; Diabetes; Oncology

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By Type: Biosimilar; Simple Generic; Super Generic

4) By Drug Delivery: Oral; Inectables; Dermal/Topical; Inhaler

Companies Mentioned: Teva Pharmaceuticals; Mylan NV; Sandoz International GmbH; Hospira (Pfizer Inc.); Sun Pharmaceutical

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Generic Pharmaceuticals Market Characteristics

3. Generic Pharmaceuticals Market Trends And Strategies

4. Impact Of COVID-19 On Generic Pharmaceuticals

5. Generic Pharmaceuticals Market Size And Growth

  • 5.1. Global Generic Pharmaceuticals Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Generic Pharmaceuticals Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Generic Pharmaceuticals Market Segmentation

  • 6.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • CNS
  • Cardiovascular
  • Dermatology
  • Genitourinary/Harmonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • 6.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Biosimilar
  • Simple Generic
  • Super Generic
  • 6.4. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Inectables
  • Dermal/Topical
  • Inhaler

7. Generic Pharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Generic Pharmaceuticals Market

  • 8.1. Asia-Pacific Generic Pharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Generic Pharmaceuticals Market

  • 9.1. China Generic Pharmaceuticals Market Overview
  • 9.2. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Generic Pharmaceuticals Market

  • 10.1. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Generic Pharmaceuticals Market

  • 11.1. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Generic Pharmaceuticals Market

  • 12.1. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Generic Pharmaceuticals Market

  • 13.1. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Generic Pharmaceuticals Market

  • 14.1. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Generic Pharmaceuticals Market

  • 15.1. Western Europe Generic Pharmaceuticals Market Overview
  • 15.2. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Generic Pharmaceuticals Market

  • 16.1. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Generic Pharmaceuticals Market

  • 17.1. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Generic Pharmaceuticals Market

  • 18.4. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Generic Pharmaceuticals Market

  • 19.1. Eastern Europe Generic Pharmaceuticals Market Overview
  • 19.2. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Generic Pharmaceuticals Market

  • 20.1. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Generic Pharmaceuticals Market

  • 21.1. North America Generic Pharmaceuticals Market Overview
  • 21.2. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Generic Pharmaceuticals Market

  • 22.1. USA Generic Pharmaceuticals Market Overview
  • 22.2. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Generic Pharmaceuticals Market

  • 23.1. South America Generic Pharmaceuticals Market Overview
  • 23.2. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Generic Pharmaceuticals Market

  • 24.1. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Generic Pharmaceuticals Market

  • 25.1. Middle East Generic Pharmaceuticals Market Overview
  • 25.2. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Generic Pharmaceuticals Market

  • 26.1. Africa Generic Pharmaceuticals Market Overview
  • 26.2. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Generic Pharmaceuticals Market Competitive Landscape And Company Profiles

  • 27.1. Generic Pharmaceuticals Market Competitive Landscape
  • 27.2. Generic Pharmaceuticals Market Company Profiles
    • 27.2.1. Teva Pharmaceuticals
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Mylan NV
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Sandoz International GmbH
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Hospira (Pfizer Inc.)
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Sun Pharmaceutical
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Generic Pharmaceuticals Pipeline Analysis

29. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

30. Generic Pharmaceuticals Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer